Bayer CEO says company is negotiating a most-favored-nation trade pact with US administration
read at Endpoints ↗RegulatoryNeutral
Bayer chief executive Bill Anderson announced the drugmaker is actively pursuing a most-favored-nation (MFN) agreement with the United States.
The comment signals that Bayer is in talks with the Trump administration to secure preferential trade terms that could influence pricing and market access for its products.
No specifics on timing or conditions were disclosed, and the company did not detail how a potential MFN deal would affect its operations.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Bayer CEO says company is ‘working on’ MFN in the US”
read at Endpoints ↗91 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that